U.S. market Closed. Opens in 2 hours 54 minutes

RLAY | Relay Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue25.55M1.38M3.03M82.65MN/AN/A
Cost of Revenue5.27M4.13M3.92M3.55M2.85M2.15M
Gross Profit20.28M-2.75M-896.00K79.11M-2.85M-2.15M
Operating Expenses398.55M312.33M230.04M138.45M84.05M49.89M
Selling, General & Admin74.95M65.98M57.39M38.59M13.74M8.86M
Research & Development330.02M246.35M172.65M99.86M70.31M41.03M
Other Operating ExpensesN/A-20.00K-4.00K-16.00K-58.00K-9.00K
Operating Income-373.00M-299.27M-364.70M-55.80M-84.05M-49.89M
Other Expenses / Income31.03M8.77M826.00K3.38M8.74M1.10M
Before Tax Income-341.97M-290.51M-363.87M-52.41M-75.31M-48.78M
Income Tax ExpensesN/A-36.25M132.94M-3.40M-8.80M1.10M
Net Income-341.97M-254.26M-496.81M-49.01M-66.50M-48.78M
Interest ExpensesN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding122.58M112.23M95.14M42.62M4.28M2.49M
Diluted Shares Outstanding122.58M112.23M95.14M42.62M4.28M2.49M
EBITDA-374.15M-306.82M-222.18M-52.25M-81.20M-47.73M
EBITDA Margin-1,464.62%-22,217.38%-7,335.16%-63.21%0.00%0.00%
EBIT-341.97M-290.51M-363.87M-52.41M-75.31M-47.68M
EBIT Margin-1,338.66%-21,036.13%-12,012.94%-63.41%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙